NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001918

Registered date:01/05/2009

Prevention of early asthma in childhood trial with pranlukast in Mie; PROACT-Mie

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedWheezing syndrome in infants
Date of first enrollment2005/11/01
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)pranlukast and as-needed beta agonists as-needed beta agonists

Outcome(s)

Primary Outcomewheezing episodes during and after treatment with pranlukast
Secondary Outcomerate of dropout because of persistent asthma symptoms

Key inclusion & exclusion criteria

Age minimum6months-old
Age maximum24months-old
GenderMale and Female
Include criteria
Exclude criteriaWheezing due to congenital anatomical anomaly, wheezing due to mediatinal neoplasm, croup syndrome, foreign body in the airways, heart diseases, pneumonia, tuberculosis, administration of leukotriene receptor antagonists, cromolyns, anti-histamines, severe liver/renal/heart diseases

Related Information

Contact

public contact
Name Yuki Yamamoto
Address 357 Osato-kubota, Tsu, Mie, Japan Japan
Telephone 059-245-6355
E-mail fujisawa@mie-m.hosp.go.jp
Affiliation Mie National Hospital Department of clinical trials
scientific contact
Name Takao Fujisawa
Address 357 Osato-kubota, Tsu, Mie, Japan Japan
Telephone 059-245-6355
E-mail
Affiliation Mie National Hospital Institute for clinical research